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Papillomaviruses occasionally cause severe, nonregressing or recurrent infections in their human and animal hosts. The
mechanisms underlying these atypical infections are not known. Canine oral papillomavirus (COPV) typically regresses
spontaneously and is an important model of mucosal human papillomavirus infections. A severe, naturally occurring,
nonregressing COPV infection provided an opportunity to investigate some aspects of viral pathogenicity and host immunity.
In this case, the papillomas proved refractory to surgical and medical treatments, including autogenous vaccination and
vaccination with capsid (L1) virus-like particles. High levels of induced anti-L1 antibodies appeared to have no effect on the
infection. The papillomas spread to oesophageal mucosa, perioral haired skin, and remote cutaneous sites. Isolation of COPV
from the animal and sequencing of several regions of the viral genome showed no differences to the COPV prototype.
Experimental infection of beagle dogs with this viral isolate resulted in the uncomplicated development and regression of oral
warts within the usual period, indicating that the virus was not an unusual pathogenic variant. These findings support the
hypothesis that the recurrent lesions seen in some human papillomavirus infections, such as recurrent laryngeal papillo-
matosis, are associated with specific defects in host immunity rather than variations in viral pathogenicity. © 1999 Academic
PressKey Words: HPV; COPV; VLP; vaccine; immunity; recurrent papillomatosis.
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qINTRODUCTION
The papillomaviruses are a ubiquitous group of patho-
ens infecting the skin and internal squamous mucosae
f most vertebrate species, including humans. These are
lassified by genotype, and to date, more than 80 types
f human papillomavirus (HPV) have been isolated and
equenced (Delius et al., 1998), with more than 130 types
dentified by detection of capsid (L1) encoding DNA (de
illiers, 1997). The viruses are associated with a spec-
rum of epithelial atypia, ranging from benign epithelial
roliferations (warts) to cancer. Different viral types in-
uce warts on skin, oropharynx and nasopharynx, larynx,
nd anogenital tissue. The types infecting the anogenital
ract have received considerable attention. Anogenital
arts, induced mainly by HPV-6 and -11, are the most
ommon viral sexually transmitted disease in the United
ingdom (Howett et al., 1997). The erratic natural history
f these lesions represents a significant therapeutic
hallenge. Infection with a subset of genital HPV types is
trongly associated with the subsequent development of
arcinoma of the uterine cervix and other anogenital
1 To whom reprint requests should be addressed. Fax: 44-(0)1707-
c61464. E-mail: pnicholl@rvc.ac.uk.
365alignancies in women, to the extent that HPV-16 and
18 have been defined as human carcinogens (Anon.,
996), with more than 90% (Bosch et al., 1995) and maybe
ll (Walboomers and Meijer, 1997) cervical carcinoma
issues positive for HPV DNA. Papillomavirus infections
herefore do not result in trivial, albeit unsightly se-
uelae, but are associated with life-threatening dis-
ases. The development of strategies for the prevention
r treatment of these infections is a high priority.
The development of such strategies requires an un-
erstanding of the host response to infection, which
ust encompass both innate and acquired immune de-
ences. Papillomavirus infections result in lesions that
ersist for a variable period ranging from weeks to
onths or years. The infectious cycle of the virus is one
n which viral replication, high-level expression of viral
roteins, and viral assembly occur in terminally differen-
iating epithelial cells remote from systemic immune de-
ences and destined for death by apoptotic or similar
echanisms. The production of infectious virus is not
ccompanied by inflammation, and the activation of host
efences is late. The importance of host immunity in the
ontrol of papillomavirus infections is demonstrated in
ndividuals immunocompromised either as a conse-
uence of other diseases such as human immunodefi-
iency virus or by therapeutic immunosuppression after
0042-6822/99 $30.00
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366 NICHOLLS ET AL.rgan transplantation (Palefsky et al., 1998). These peo-
le exhibit persistent and florid HPV-induced lesions that
re refractory to therapy. However, even in immunocom-
etent individuals, there is a spectrum of responses to
nfection, ranging from clearance of virus with no clinical
isease to persistent lesions refractory to all treatment
odalities (Beutner and Ferenczy, 1997). This latter sce-
ario is seen dramatically in individuals with recurrent
espiratory papillomatosis (RRP). The general view is that
ndividuals with persistent and recurrent florid infections
f the type seen in RRP have an underlying and specific
nability to mount a response to certain HPV types. How-
ver, it is possible that such infections are the conse-
uence of infection with viral variants with an enhanced
athogenicity, including immune evasion mechanisms.
Testing these hypotheses in humans is beset with
thical and logistical difficulties, but natural papillomavi-
us infections in animals could illuminate these issues.
anine oral papillomavirus (COPV) infection is a valuable
odel for the analysis of many aspects of papillomavirus
athogenesis. COPV induces florid warts on the oral
ucosa in domestic dogs and wild canids (for a review,
ee Nicholls and Stanley, 1999). Typically, COPV infection
FIG. 1. Nonregressing canine oral papillomatosis. Multiple crops
xtending onto the perioral haired skin (b). Papillomas of the buccal mu
ar, 1 cm.as an incubation period of 4–8 weeks followed by spon- faneous immune-mediated regression within an addi-
ional 4–8 weeks (Chambers and Evans, 1959). Persis-
ence or neoplastic progression of COPV-induced papil-
omas has rarely been reported. In this report, we
escribe a case of naturally occurring COPV infection in
hich the papillomas failed to regress and were refrac-
ory to all treatments, including vaccination. High levels
f anti-L1 antibody were present throughout the period of
nvestigation and after vaccination with L1 virus-like par-
icles (VLPs) and an autogenous vaccine. Isolation of
OPV from the animal and sequencing of several re-
ions of the viral genome showed no differences to the
OPV prototype. Experimental infection of beagle dogs
ith this viral isolate resulted in the uncomplicated de-
elopment and regression of oral warts within the usual
eriod, indicating that the virus was not an unusual
athogenic variant.
RESULTS
A 3.5-year-old neutered female laborador with severe
ral papillomatosis (Fig. 1) was presented to one of the
uthors (B.K.). Diagnosis was established by histology of
llomas affect the buccal mucosa, tongue, and palatine mucosa (a),
) and tongue (d) show multiple filiform papillae typical of mature warts.of papi
cosa (cormalin-fixed paraffin-embedded tissue, immunohisto-
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367NONREGRESSING COPV INFECTIONhemical detection of the L1 viral capsid protein, in situ
etection of COPV DNA (Fig. 2), and electron micro-
copic detection of viral particles (Fig. 3).
The initial removal of the warts with electrocautery
as followed in 3 weeks by the appearance of a more
bundant recurrent crop. During the next 8 months, fur-
her attempts to resolve the disease included electrocau-
ery, surgical crushing of warts (to stimulate immunity),
ral interferon-a, oral levamisole, intravenous immuno-
egulin, intravenous vincristine, subcutaneous vaccina-
ion with COPV L1-VLPs (five doses), and subcutaneous
accination with an autogenous vaccine derived from
omogenised warts (Table 1). No significant response
as seen, and the dog was euthanized. Postmortem
xamination revealed papillomas throughout the oral
avity and extending down the oesophagus (Fig. 4). Pap-
llomas were seen on the haired skin of the face, as well
s more remote cutaneous sites such as the pinna and
orelimbs. Examination of material removed post mortem
onfirmed the presence of COPV in the lesions from
FIG. 2. Confirmation of diagnosis. Histological examination of haem
koilocytic) keratinocytes typical of productive papillomavirus infections.
f the stratum granulosum (c). In situ hybridisation for COPV genomic D
f). Normal canine buccal mucosa (d) is included for comparison and i
, d, and f, 2003; b, 4003; and e, 1003.esophagus (Fig. 5), haired skin, and oral cavity. These pata add oesophageal mucosa to the tissues known to
e affected by COPV. Interestingly, a papilloma devel-
ped on perivulval skin, but a biopsy was not available
or confirmation of viral involvement.
No significant lymphocyte infiltrate was seen in biopsy
amples of the papillomas. This is in contrast to the findings
n warts regressing after experimental infection, in which
umerous infiltrating CD41 and CD81 cells are present
manuscript in preparation). There was no haematological
vidence of immunosuppression. The total white cell count
as 7800/ml, which is at the low end of the normal range
8–18,000/ml). The neutrophil count was 5900/ml (normal
ange, 3–12,000/ml) and the lymphocyte count was 1900/ml
normal range, 1000–4800/ml). Serum protein electrophore-
is revealed increased g-globulins (1.28 g/dl; normal range,
.4–1.0). Unfortunately, logistical factors prevented the un-
ertaking of lymphocyte functional assays; the affected dog
United States) and the authors’ laboratories (UK) were
idely separated. No siblings of the affected dog were
raceable, so a possible familial predisposition to florid
and eosin-stained sections (a and b) reveals superficial vacuolated
ohistochemistry reveals abundant viral capsid antigen (L1) in the cells
nfirms the presence of abundant viral DNA in affected epithelial cells
ive for viral DNA by in situ hybridisation (e). Original magnification: a,atoxylin
Immun
NA co
s negatapillomatosis could not be assessed.
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368 NICHOLLS ET AL.To determine whether the severe clinical signs were
ue to an unusually pathogenic strain of COPV, the virus
as isolated and injected into beagles. The lesions ap-
eared and regressed normally. PCR amplification and
equencing of several regions of the isolated viral DNA
Table 2), including the entire L1 open reading frame,
howed no differences from the COPV prototype se-
uence determined by Delius et al. (1994). In addition,
ositive immunohistochemistry findings (data not shown)
ith a COPV E4 antibody, raised against E4 derived from
he prototype COPV sequence, further confirms the iden-
ity of this viral isolate, because E4 is highly divergent
etween papillomaviruses.
Serum samples were collected weekly during the pe-
iod of vaccination with COPV L1 VLPs and autogenous
accine. Sera were analysed by ELISA, using purified
OPV virions as the antigen (Fig. 6). Sequential serum
amples demonstrated an increase in specific antibody
iter during the course of the infection. Vaccination with
OPV VLPs or an autogenous wart homogenate was not
ssociated with any clinical response, despite the pres-
nce of high antibody titres. The IgG antibody titres were
reater than those from normal control dogs (mean titer
f six normal beagles before infection with COPV).
DISCUSSION
Various efforts have been made to demonstrate the
nfluence of the immune system on the outcome of pap-
llomavirus infection. Early studies failed to demonstrate
ncreased persistence of papillomas in rabbits immuno-
uppressed using cortisone (Evans et al., 1962). There
re, however, occasional reports of severe or gener-
lised papillomatosis in dogs immunosuppressed by
rednisolone (Sundberg et al., 1994; Nagata et al., 1995;
e Net et al., 1997). Oral papillomatosis has been seen
ressing Canine Papillomatosis
Date
December 1, 1997
December 4, 1997; January 22, April 10, April 30, and June 3, 1998
December 22, 1997
January 29, February 5, and April 2, 1998
February 11, March 25, and April 2, 1998
February 11–17 and 24–30, 1998
April 2 to May 10, and June 30 to August 30, 1998
April 10, 15, 18, 22, and 30, and June 3, 1998
April 10 to May 5, and June 3–10, 1998
May 8, 16, and 22 (all 0.6 mg), and May 29, (0.75 mg) 1998
June 6, 1998
June 12, 19, and 25, and July 2, 1998
July 2, 1998
July 9 (1 ml), 15 (1.5 ml), 22 (2 ml), and 29 (3 ml), 1998
August 6, 1998FIG. 3. Electron microscopy of canine oral papillomas. Abundant
irions, both free and in close-packed crystalline arrays, are seen in
he nucleus of superficial keratinocytes within the papillomas. The
uclear envelope is seen crossing toward the top of the picture.TABLE 1
Clinical Summary of a Case of Nonreg
Treatment/clinical observations
irst presented for oral papillomatosis
urgical removal of oral papillomas, with electrocautery
irst recurrence of lesions
apillomas crushed with haemostats
apillomas plucked with haemostats
ral interferon-a (300 IU), once a day
ral levamisole (75 mg), every other day
ntravenous immunoregulin (1.5 ml)
ral enrofloxacin (100 mg) once a day
ntravenous vincristine (0.6 mg)
OPV L1 VLP vaccine (20 mg) with aluminium hydroxide, subcutaneously
ooster COPV L1 VLP vaccine, without adjuvant, subcutaneously
irst dose of autogenous wart homogenate vaccine (1 ml), subcutaneously
ooster autogenous wart homogenate vaccine, subcutaneously
uthanasia due to persistent papillomatosis of oral cavity, including larynx
and perioral haired skin, and other cutaneous sites
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369NONREGRESSING COPV INFECTIONlso in a dog with hypogammaglobulinaemia (Bredal,
996), and another report described multiple cutaneous
quamous papillomas associated with IgM deficiency
nd impaired T-cell responses (Mill and Campbell, 1992).
tudies in cattle support the hypothesis that immunosup-
ression after bracken feeding (Campo et al., 1992, 1994)
r azathioprine treatment (Campo et al., 1992) worsens
apillomavirus-associated disease, with lesions becom-
ng extensive, extending down the oesophagus to the
umen without regression. The extension of nonregress-
ng papillomas along the oesophagus in immunosup-
ressed cattle may be analogous to the findings in the
og reported here. Similar associations are documented
n humans immunosuppressed by human immunodefi-
iency virus infection or iatrogenic means (Stark et al.,
994; Benton and Arends, 1996). Occasionally, persistent
nd generalised HPV infections, refractory to treatment,
ave been associated with primary immunodeficiency
Gaspari et al., 1997).
The unusual natural COPV infection reported here
rovided an opportunity to investigate some aspects of
onregressing papillomatosis. The differential white cell
ount provided no haematological evidence of immuno-
uppression. The dog did not have signs of unusual or
evere bacterial, protozoal, or fungal infections, as might
e expected in cell-mediated immunodeficiency. Serum
rotein electrophoresis demonstrated raised g-globulin
FIG. 4. Postmortem findings. At postmortem examination, papillom
mmediately surrounding the larynx (a). Additionally, papillomas were fevels, probably due to increased immunoglobulins as- vociated with an active B-cell immune response. ELISA
emonstrated the presence of high titres of anti-COPV
gG. These findings indicate that successive crops of
arts were able to occur despite the presence of neu-
ralising antibody. Although the dog already had severe
apillomatosis at first presentation, it is possible that the
irst episode of electrocautery may have allowed the
irus to establish latency in numerous keratinocytes
ithin the traumatised and regenerating epithelium. La-
ency has been demonstrated in other animal papilloma-
irus infections (Amtmann et al., 1984; Campo et al.,
994) and also seems to occur in RRP. Once latent
nfection was established, the presence of neutralising
ntibody would have been unable to prevent develop-
ent of lesions from the infected keratinocytes. The
umerous episodes of epithelial trauma, associated with
ive electrocautery sessions, may have caused reactiva-
ion of latent infections by the stimulation of epithelial
roliferation and healing. Surgical interference has been
ocumented as exacerbating papillomatosis in the dog
Collier and Collins, 1994). Although no published data
ddress the issue of breed-related variations in re-
ponse to papillomavirus infection, the authors (includ-
ng a veterinary pathologist and a veterinary clinician)
ave seen multiple biopsies and clinical cases of un-
omplicated wart regression in laborador dogs (unpub-
ished observations) and are unaware of any such breed
e found to be widespread within the oral cavity, including the area
xtending along the oesophagus (a–c). Bar, 1 cm.as werariations. These observations and the absence of sig-
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370 NICHOLLS ET AL.ificant lymphocyte infiltration in the clinical biopsies
uggest that defective cellular immunity allowed warts to
ersist. Infection by a more pathogenic variant of COPV
ould be an alternative explanation. Sequence variants
ith differing pathogenicity have been described for
ome HPVs (Xi et al., 1997) and in the rabbit (Salmon et
l., 1997). Infection with a more pathogenic variant of
OPV was shown by sequencing and experimental in-
ections not to be the cause of the unrestricted viral
eplication described in the present case.
The ELISA data from this unfortunate dog show that
accination with VLPs and increased antibody titres to
FIG. 5. Identification of viral DNA and capsid antigen in oesophagea
s detected by in situ hybridisation. Adjacent unaffected epithelium is fr
nd positive (right) mucosa (c). Viral capsid (L1) antigen, detected by im
tratum granulosum and stratum corneum (b and d). Sections a and bhe wild-type viral particle failed to alter the course of an lstablished infection, despite the titres being greater
han those that would normally prevent reinfection. The
evelopment of high anti-capsid antibody titres is clearly
neffective in the removal of established papilloma infec-
ions, and the design of immunotherapeutic strategies
ill have to take this into account.
The findings presented here document a new tropism
or COPV, with viral infection not confined to the oral
ucosa but extending throughout the oesophagus and
lso involving perioral haired skin and remote cutaneous
ites. Additionally, these data show clearly that the de-
elopment of humoral immunity can neither clear estab-
s. Viral DNA was abundant within oesophageal papillomas (a and c),
tectable viral DNA, giving a sharp demarcation between negative (left)
istochemistry, was present in scattered superficial keratinocytes of the
rially adjacent. Magnification: a and b, 1003; and c and d, 2003.l lesion
ee of de
munohished papillomavirus infections nor, under certain cir-
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371NONREGRESSING COPV INFECTIONumstances, prevent recurrent infections. Furthermore,
hese findings demonstrate that a virus normally causing
nsignificant spontaneously regressing papillomas can
ause debilitating disease in some individuals. The most
ikely explanation of the phenomena in this animal is that
ost immunity was compromised. However, if this expla-
ation is correct, the immune defect could be subtle,
ecause the dog exhibited no other obvious signs of
mmune deficiency in either its haematological values or
ts susceptibility to other opportunist pathogens.
These findings support the hypothesis that the recur-
ent lesions seen in some HPV infections, such as RRP,
re associated with specific defects in host immunity
ather than with variations in viral pathogenicity. In addi-
ion, persistent papillomavirus infections in some individ-
als are unlikely to be responsive to therapeutic vacci-
ation, highlighting the need for a greater understanding
f the biology of papillomavirus-associated diseases to
acilitate the development of nonimmunological thera-
ies.
MATERIALS AND METHODS
mmunohistochemistry
Paraffin sections of formalin-fixed tissue were cut onto
T
PCR Amplification and Sequencing of Purified COPV D
Primer
artial ORF series
COPV E1 P1: caatcgaattctgaggggcaaagacaggtag 330
P2: taataggatccgcacaaacaaacataataat
COPV E1b P1: atcgtaggatccaaatatcttcgcagcagatg 243
P2: atcgtagaattctcatacagactcagtagttcc
COPV E2 P1: caacagaattcaagggcataatgaggatagg 385
P2: attcgggatccataatacacctgctgagtcc
COPV E2b P1: agctggggatcctaatagttt 259
P2: atcgtagaattcttataactcatctaaccctcc
COPV E4 P1: cacttgaattccggtgcctgttcccttaccc 257
P2: atcttggatcccagaagtcttcccagtcgtc
COPV E6 P1: caacggaattcgatctttgcatgtctctaaa 363
P2: atctcggatccctgaccacagaaaaatcgtt
COPV E7 P1: caactgaattcgagcagccggagccgataga 187
P2: attcgggatccatcctctttttgagacagac
COPV L1 P1: catccgaattcatgtccaccaatagaactga 381
P2: caactggatccgtccctcactagaaaccaga
COPV L2 P1: caacggaattcaagattaccactgatgctca 362
P2: atcttggatccgctgatatcttcgcctatta
ull ORF series
COPV E1 P1: atcgtaggatccatggcggctagaaaaggtact 1818
P2: atcgtagaattctcatacagactcagtagttcc
COPV E2 P1: atcgtaggatccatggagaaactcagcgaggcc 1182
P2: atcgtagaattcttataactcatctaaccctcc
COPV E7 P1: atcgtaggatccatgattgggcaatgcgcaac 318
P2: atcgtagaattcctagccgccatggtcaagct
COPV L1 P1: atcgtaggatccatggcggtttggcttcctgc 1536
P2: atcgtagaattcttatttgcgtttgcgtttcaectabond-coated slides (Vector Laboratories, Peterbor- iugh, UK), dewaxed (33 5 min) in xylene (BDH Labora-
ory Supplies, Poole, UK), and rehydrated through etha-
ol (BDH) dilutions (100%, 100%, 95%, 70%, and 30%, for 3
in each). After two 3-min washes in PBS (Department of
athology, University of Cambridge, Cambridge, UK), en-
ogenous peroxide was quenched for 30 min in 0.3%
ydrogen peroxide (Fisons, Loughborough, UK) in PBS.
fter washing in PBS (33 3 min), sections were incu-
ated in normal goat serum (20% in PBS) for 30 min at
oom temperature. The goat serum was blotted off, and
he primary antibody (CAMVIR-1 mouse IgG2a monoclo-
al antibody diluted 1:1000 in PBS; Department of Pathol-
gy, University of Cambridge) was applied overnight at
°C in a humid box. After washing as above, the sec-
ndary antibody (biotinylated polyclonal goat anti-mouse
gG2a1:400 in PBS; Amersham) was applied for 30 min.
lides were washed and then incubated for 30 min in
eroxidase-conjugated avidin–biotin complex (Vec-
astain Elite; Vector Laboratories). After washing, the
hromogenic solution [0.06% 3,39 diaminobenzidine tet-
ahydrochloride, 0.01% hydrogen peroxide in 0.1 M Tris
BDH), pH 7.5] was applied, and the reaction was moni-
ored by microscopy until completion. After washing, the
ections were counterstained (Carazzi’s haematoxylin,
5 s), dehydrated through graded alcohols, and mounted
olated from a Case of Nonregressing Papillomatosis
dicted product Size by electrophoresis
uding nt 1199–1506 300–394 bp (confirmed by sequencing)
uding nt 2391–2609 Close to 234 bp (confirmed by sequencing)
luding nt 2694–3058 Close to 394 bp (confirmed by sequencing)
uding nt 3460–3710 234–298 bp (confirmed by sequencing)
uding nt 3193–3429 234–298 bp (confirmed by sequencing)
uding nt 150–492 298–394 bp (confirmed by sequencing)
uding nt 575–740 154–234 bp (confirmed by sequencing)
uding nt 7397–7755 Close to 394 bp (confirmed by sequencing)
uding nt 5771–6110 298–394 bp (confirmed by sequencing)
luding nt 816–2608 1.6–2.0 kb (not sequenced)
luding nt 2551–3708 1.0–1.6 kb (not sequenced)
uding nt 533–826 Close to 344 bp (not sequenced)
luding nt 6837–8348 Just under 1.6 kb (confirmed by sequencing)ABLE 2
NA Is
Pre
bp incl
bp incl
bp, inc
bp incl
bp incl
bp incl
bp incl
bp incl
bp incl
bp inc
bp inc
bp incl
bp incn dibutylpolystyrenexylene (BDH). Positive control sec-
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372 NICHOLLS ET AL.ions were canine oral papillomas with virions confirmed
y transmission electron microscopy. Negative control
ections were from normal canine oral mucosa.
NA in situ hybridisation
Sections on Vectabond-coated slides (Vector Labora-
ories) were dewaxed and rehydrated as above and
ashed in PBS (23 3 min). After protease K digestion in
humidified box (50 mg/ml in 0.02 M Tris, pH 7.4, and 2
M CaCl2 for 15 min at 37°C), sections were washed in
BS (23 5 min), dehydrated through graded alcohols (30
each), and air dried. The section was covered in a
igoxigenin-labeled, nick-translated (Boehringer Ingle-
eim, Ridgefield, CT) genomic COPV DNA probe diluted
:25 in hybridisation buffer [23 SSC, 5% dextran sulfate,
.2% Marvel (Premier Beverages), and 50% deionised
FIG. 6. Parallel ELISA titration of serum samples from a dog with no
accination with COPV L1 VLPs and autogenous wart homogenate. A r
esolution of the lesions. The control data represent mean titres from
Plate no. Sample no. Titre
1 1a 4,910
1 2 33,350
1 3 26,680
1 4 24,970
2 1b 4,450
2 5 24,325
2 6 23,550
2 7 16,600
3 1c 4,870
3 8 21,160
3 9 11,840
3 10 22,497ormamide], coverslipped and sealed with cow gum 9Cow Proofings Ltd., Slough, UK). After denaturation on a
ot plate (6 min at 95°C), slides were quenched in an ice
ath and then incubated overnight at 37°C.
The gum was removed with forceps, and the cover-
lips were soaked off in 23 SSC and 0.1% SDS. Slides
ere washed at room temperature in 0.53 SSC (33 5
in) at 55°C in 50% formamide/13 SSC for 10 min and at
5°C in 0.53 SSC (33 5 min). After 30 min in 0.5%
locking buffer (Boehringer Ingleheim), the sections
ere rinsed briefly in buffer 1 (0.1 M Tris, pH 7.5, 0.1 M
aCl, 2 mM MgCl2, and 0.05% Triton-X 100) and covered
ith 100 ml alkaline-phophatase conjugated anti-digoxi-
enin Fab fragments (Boehringer Mannheim Bio-
hemica, Mannheim, Germany) 1:5000 in buffer 1 for 1 h
n a humid box. The slides were washed in buffer 1 (33
min), equilibrated for 5 min in buffer 3 (0.1 M Tris, pH
ssing COPV lesions. Sera were taken before and during the period of
iter is seen during the course of the infection, but this failed to cause
fected beagles.
ing of sample
ruary 11, 1998 Prevaccination
6, 1998 1st dose VLPs
12, 1998 2nd dose VLPs
19, 1998 3rd dose VLPs
ruary 11, 1998 Prevaccination (repeat sample)
25, 1998 4th dose VLPs
2, 1998 5th dose VLPs/1st autogenous vaccine
9, 1998 2nd autogenous vaccine
ruary 11, 1998 Prevaccination (repeat sample)
15, 1998 3rd autogenous vaccine
22, 1998 4th autogenous vaccine
29, 1998 5th autogenous vaccinenregre
ise in t
six unin
Tim
Feb
June
June
June
Feb
June
July
July
Feb
July
July
July.5, 0.1 M NaCl, and 50 mM MgCl2), and then covered
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373NONREGRESSING COPV INFECTIONith 100 ml of 0.18 mg/ml 5-bromo-4-chloro-3-indolyl
hosphate (Boehringer Mannheim) and 0.34 mg/ml ni-
roblue tetrazolium chloride (Boehringer Mannheim) in
uffer 3 and developed in the dark overnight. The reac-
ion was stopped in TE buffer for 10 min, and the sections
ere counterstained, washed in distilled water (23 5
in), and mounted in Aquamount (Gurr, BDH Laboratory
upplies, Poole, UK).
lectron microscopy
Tissue cubes (1 mm) were dewaxed by three changes
f xylene over 2 h. After 15 min in 100% ethanol, the
amples were placed in 2% osmium tetroxide for 1 h
efore being dehydrated via graded ethanols (40%, 70%,
nd 90%, for 10 min each, followed by 100% for 33 15
in). After submersion in propylene oxide (23 15 min),
he samples were placed overnight in a 1:1 mixture of
ropylene oxide and embedding resin [68% (v/v) dodecyl
uccinic anhydride, 32% (v/v) methyl nadic anhydride,
nd 4% (v/v) dimethylaminomethyl phenol]. The next
orning, the samples were placed into resin for 6 h
efore embedding and baking overnight. Sections were
xamined under an Hitachi H-100 electron microscope.
LISA
Flexible PVC microplates were coated with 100 ng/
ell of purified COPV particles suspended in carbonate
uffer, pH 9.6, at 4°C overnight. The plates were washed
ith PBS/0.05% Tween 20 and blotted dry before the
ddition of 100 ml/well of PBS/Tween containing 2% w/v
kimmed milk powder (ELISA diluent) and incubation at
7°C for 30 min. After further washing, 50-ml aliquots of
ndividual serum dilutions, from a doubling series made
or each canine serum sample, were added to duplicate
ells of the coated plates. Negative controls received
iluent alone. The plates were reincubated at 37°C for
.5 h and washed again, and then peroxidase-conju-
ated, rabbit anti-dog IgG (1:500; ICN Immunobiologi-
als, Thame, UK) was added to all wells. After incubation
or an additional 1.5 h and a final wash, the plates were
eveloped using an s-phenylene diamine/peroxide sub-
trate in urea buffer (Sigmafast; Sigma Chemical, St.
ouis, MO). Colour development was stopped with 20%
ulphuric acid, and absorbance levels were read at 490
m with a Molecular Devices (Sunnyvale, CA) plate
eader. The titer was expressed as the reciprocal of the
ilution producing 50% of the maximum absorbance.
iral isolation
Fresh frozen papillomas were diced finely and added
o 15 ml of PBS before Dounce homogenisation (Jencons,
eighton Buzzard, UK). Both supernatant and debris were
aved and processed separately.
The supernatant was poured off and centrifuged for 20
in in a Sorval SS34 rotor at 7500 rpm to pellet the Puclei. The pellet was resuspended in 4 ml of PBS and
onicated (Soniprep 150; MSE, Loughborough, UK) on
ce for 1 min at power level 22. The lysate was layered
nto 0.75 ml of sucrose and centrifuged in an SW55Ti
otor at 34,000 rpm for 2 h at 18°C. The pellet was
esuspended in 2 ml of PBS before further sonication on
ce for 10 s. Caesium chloride solution (1.92 g in 3 ml of
BS; refractive index, 1.381) was added and mixed by
nversion. The refractive index was confirmed (Refrac-
ometer model 60/ED; Bellingham and Stanley, Tunbridge
ells, UK) as 1.365 (1.33 g/cm3) before centrifugation in
n SW55 Ti rotor at 34,000 rpm for 18 h at 18°C. The viral
and was extracted, and sealed in dialysis tubing (Medi-
ell, Liverpool, UK), and dialysed against PBS for 4 h.
iral challenge
Tenfold serial dilutions of the purified COPV isolate in
volume of 50 ml were injected superficially with a
5-gauge needle into the mucosa of the upper lip of the
eagles under general anaesthesia. The resulting vesi-
le or bleb was then punctured superficially 10 times
ith the same needle. Control sites received PBS in-
tead of viral solution.
iral PCR and sequencing
Primer pairs to regions within each of the viral open
eading frames were designed and synthesised. To each
.5-ml Eppendorf tube, we added 72 ml of distilled water,
ml of dNTPs (10 mM each of dATP, dGTP, dCTP, and
TTP; Pharmacia, St. Albans, Herts, UK), 5 ml of 5 mM
rimer 1, 5 ml of 5 mM primer 2, 5 ml (approximately 20 ng)
f COPV DNA (extracted from fresh warts of the affected
og), and 10 ml of 103 Taq buffer and 1 ml of Taq
olymerase (both from Enzyme Technologies, HT Bio-
echnology Ltd., Cambridge, UK). To run all reactions
ogether, a stepped annealing temperature was built into
he cycle. Using a GeneAmp 9600 thermal cycler (Per-
in–Elmer), a 5-min 94°C step was followed by 30 cycles
f 94°C, 53.4°C, 57.1°C, 58.1°C, 63.6°C, and 72.0°C for 1
in each, with a final annealing step of 72°C for 5 min
efore cooling to 4°C. The products were analysed by 1%
garose gel electrophoresis along a 100-bp DNA ladder
GIBCO, Paisley, Scotland).
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